About Mark McCarty

Mark McCarty has one of the deepest reservoirs of experience in med tech regulatory matters in the trade press. His experience includes managing editorship of publications such as Warning Letter Bulletin and Inspection Monitor, and he served for two decades as the regulatory editor for Medical Device Daily and its successor publication, BioWorld MedTech.

 Mark has covered FDA and other regulatory bodies along with Medicare reimbursement, False Claims Act litigation, patent litigation, and a variety of enforcement matters as well. In addition, he has written extensively on regulation outside the U.S., artificial intelligence, cardiology and oncology. Mark offers coverage of not just the day’s news, but also the context of these latest developments that provides an understanding of the implications of the news. He can be found here on LinkedIn.

Access all areas

By signing up, you'll get access to the full archive of everything that's been published before and everything that's still to come. Your very own private library.

Fresh content, delivered

Stay up to date with new content sent straight to your inbox! No more worrying about whether you missed something because of a pesky algorithm or news feed.